Caixin
Aug 21, 2021 08:00 AM

Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Dropped 49.3% in First Half of 2021

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 49.4 million yuan in the first half of 2021, down 49.3% year-on-year.

Meanwhile, the company posted 386.8 million yuan in revenue, up 17.8% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 772.3 million yuan in total liabilities, with a liability-to-asset ratio of 32.7%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST